Applications of optical coherence tomography in cardiovascular medicine, Part 2
- PMID: 19479314
- PMCID: PMC4352576
- DOI: 10.1007/s12350-009-9100-2
Applications of optical coherence tomography in cardiovascular medicine, Part 2
Figures

















Similar articles
-
Drug-coated balloon without stent implantation for chronic total occlusion of coronary arteries: Description of a new strategy with an optical coherence tomography assistance.Int J Cardiol. 2015 Jul 15;191:75-6. doi: 10.1016/j.ijcard.2015.04.278. Epub 2015 May 2. Int J Cardiol. 2015. PMID: 25965604 No abstract available.
-
Delayed neointimalization on drug-eluting stents--speculation from optical coherence tomography.Circ J. 2009 Dec;73(12):2210-1. doi: 10.1253/circj.cj-09-0792. Circ J. 2009. PMID: 19940371 No abstract available.
-
Drug-eluting stent treatment of left main coronary artery disease: the case for a sirolimus-eluting, autoexpandable alternative. An optical coherence tomography analysis.Int J Cardiol. 2015 Nov 15;199:119-20. doi: 10.1016/j.ijcard.2015.07.006. Epub 2015 Jul 11. Int J Cardiol. 2015. PMID: 26188831 No abstract available.
-
The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.Cardiovasc Ther. 2015 Dec;33(6):360-6. doi: 10.1111/1755-5922.12160. Cardiovasc Ther. 2015. PMID: 26363283 Review.
-
Algorithmic Approach for Optical Coherence Tomography-Guided Stent Implantation During Percutaneous Coronary Intervention.Interv Cardiol Clin. 2018 Jul;7(3):329-344. doi: 10.1016/j.iccl.2018.03.001. Epub 2018 Jun 29. Interv Cardiol Clin. 2018. PMID: 29983145 Review.
Cited by
-
Effect of glitazones on the progression of coronary artery disease in type 2 diabetes patients.Vasc Health Risk Manag. 2010 Feb 4;6:1-8. Vasc Health Risk Manag. 2010. PMID: 20191077 Free PMC article. Review.
-
Optical coherence contrast imaging using gold nanorods in living mice eyes.Clin Exp Ophthalmol. 2015 May-Jun;43(4):358-66. doi: 10.1111/ceo.12299. Epub 2015 Feb 12. Clin Exp Ophthalmol. 2015. PMID: 24533647 Free PMC article.
References
-
- Camendzind E, Nordman AJ, Briel M, Bucher HC. Safety of drug eluting stents: Insights from a meta-analysis. Presented at the European Society of Cardiology Annual Congress; 2006. Hotline I.
-
- Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med. 2007;356:998–1008. - PubMed
-
- Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schomig A, et al. Outcomes associated with drug-eluting and bare-metal stents: A collaborative network meta-analysis. Lancet. 2007;370:937–48. - PubMed
-
- Rizik DG, Klassen KJ. Assessing the landscape of stent thrombosis: The drug-eluting versus bare-metal stent controversy. Am J Cardiol. 2008;102:4J–11J. - PubMed
-
- Spaulding C. The question of drug-eluting stent safety: Then and now. Am J Cardiol. 2008;102:12J–7J. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources